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System and method for detecting cells or components thereof
Abstract
A system and method for detecting a detectably labeled cell or componentthereof in a sample comprising one
or more cells or components thereof, at least one cell or component thereof of which is detectably labeled
with at least two detectable labels. In one embodiment, the method comprises: (i) introducing the sample
into one or more flow cells of a flow cytometer, (ii) irradiating the sample with one or more light sources that
are absorbed by the at least two detectable labels, the absorption of which is to be detected, and (iii)
detectingsimultaneously the absorption of light by the at least two detectable labels on the detectably labeled
cell or component thereof with an array of photomultiplier tubes, which are operably linked to two or more
filters that selectively transmit detectable emissions from the at least two detectable labels.
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SYSTEM AND METHOD FOR DETECTING 
CELLS OR COMPONENTS THEREOF 
CROSS-REFERENCE TO RELATED PATENT 
APPLICATIONS 
This patent application claims the bene?t of US. Provi 
sional Patent Application No. 60/558,227, ?led Mar. 31, 
2004, the entire content of Which is incorporated herein by 
reference. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH AND DEVELOPMENT 
This invention Was supported in part by the US. Depart 
ment of Energy, Grant No. W-7405-ENG-82, and the US. 
Department of Agriculture, Grant No. 2002-35201-12659. 
The Government may have certain rights in this invention. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to a method for detecting a 
detectably labeled cell or component thereof in a sample 
comprising one or more cells or components thereof, at least 
one cell or component thereof of Which is detectably labeled 
With at least tWo detectable labels, and a system for use in 
such a method. Immunoassay, ?uorescence, and How cytom 
etry are employed. 
2. Description of the Related Art 
Various assays for determining qualitative and/or quanti 
tative characteristics of cells or components thereof are 
knoWn in the art. FloW cytometers, for example, are used in 
both diagnostics and research laboratories to classify and 
analyZe cells and components thereof. In How cytometry, 
cells or components thereof are typically stained With detect 
able ?uorescent labels and are passed in a liquid suspension 
through a How cell along With a sheath ?uid, such that cells or 
components thereof are forced by hydrodynamic focusing to 
How in single ?le along the center axis of the How cell. A 
focused light beam, such as a laser beam, then illuminates the 
cells or components as they ?oW through the examination 
Zone of the How cell. Optical detectors Within the How cytom 
eter measure certain characteristics of the light as it interacts 
With the cells or components thereof. Commonly used ?oW 
cytometers, such as the Becton-Dickinson Immunocytometry 
Systems “FACSCAN” (San Jose, Calif.), for example, can 
measure forWard light scatter (generally correlated With the 
refractive index and siZe of the particle being illuminated), 
side light scatter (generally correlated With the particle’s 
siZe), and ?uorescence at one or more Wavelengths. FloW 
cytometers and various techniques for theiruse are described, 
generally in “Practical FloW Cytometry” by HoWard M. Sha 
piro (Alan R. Liss, Inc., 1985) and “Flow Cytometry and 
Sorting, Second Edition” edited by Melamed et al. (Wiley 
Liss, 1990). 
While ?oW cytometry techniques have advanced greatly 
over the years, ef?cient single-step assay processes for simul 
taneously detecting multiple types of cells or components 
thereof, and for simultaneously identifying multiple charac 
teristics of individual cells or components thereof, remain 
highly desirable in the art. It Would be desirable, for example, 
to have adequate methods and systems for performing reli 
able and sensitive real-time multiple determinations, simul 
taneously, through a single or limited step assay process. A 
capability to perform simultaneous, multiple determinations 
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in a single assay process is knoWn as “multiplexing” and a 
process to implement such a capability is a “multiplexed 
assay.” 
Conventional ?oW cytometers, to this point, have yielded a 
limited capacity to perform real-time multiple determina 
tions. This is due mainly to an inability of conventional ?oW 
cytometers to receive, compute, and/or store simultaneous 
detection data. Moreover, conventional detection and enu 
meration techniques for cells or components thereof that uti 
liZe antibody-conjugated detectable labels typically yield 
unsatisfactory and unreliable cell or component counts due to 
antibody aggregations, Which yield substantial “false posi 
tives.” 
Thus, in vieW of the above, there remains a need for sen 
sitive and reliable methods and systems for the detection and 
enumeration of cells or components thereof. The present 
invention seeks to provide such a method and system. These 
and other objects and advantages of the present invention, as 
Well as additional inventive features, Will become apparent to 
those of ordinary skill in the art upon reading the detailed 
description set forth herein. 
SUMMARY OF THE INVENTION 
The present invention provides a method for detecting, 
distinguishing, and/or quantifying at least one detectably 
labeled cell or component thereof in a sample comprising one 
or more cells or components thereof, at least one cell or 
component thereof of Which is detectably labeled With at least 
tWo detectable labels. The method comprises: (i) introducing 
a sample comprising one or more cells or components 
thereof, at least one cell or component thereof of Which is 
detectably labeled With at least tWo detectable labels, into one 
or more How cells of a How cytometer, (ii) irradiating the 
sample With one or more light sources that are absorbed by the 
at least tWo detectable labels, the absorption of Which is to be 
detected, and (iii) detecting simultaneously the absorption of 
light by the at least tWo detectable labels on the detectably 
labeled cell or component thereof With an array of photomul 
tiplier tubes, Which are operably linked to tWo or more ?lters 
that selectively transmit detectable emissions from the at least 
tWo detectable labels. The tWo or more ?lters and the array of 
photomultiplier tubes are operably linked to the one or more 
light sources by one or more optical bodies that project the 
detectable emissions from the at least tWo detectable labels to 
the tWo or more ?lters. The simultaneous detection of absorp 
tion of light by the at least tWo detectable labels indicates the 
presence of a detectably labeled cell or component thereof in 
the sample. 
The present invention further provides a system for use in 
the above method. The system comprises: (i) tWo or more 
How cells, into Which can be placed a sample comprising one 
or more cells or components thereof, at least one cell or 
component thereof of Which is detectably labeled With at least 
tWo detectable labels, (ii) one or more light sources that are 
absorbed by the at least tWo detectable labels, the absorption 
of Which is to be detected, and (iii) an array of photomultiplier 
tubes, Which are operably linked to tWo or more ?lters that 
selectively transmit detectable emissions from the at least tWo 
detectable labels. The tWo or more ?lters and the array of 
photomultiplier tubes are operably linked to the one or more 
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light sources by one or more optical bodies, Which project the 
detectable emissions from the at least tWo detectable labels to 
the tWo or more ?lters. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a diagram of a system for detection of cells or 
components thereof, according to an embodiment of the 
present invention. 
FIG. 2 is a photograph of a system for detection of cells or 
components thereof. 
FIG. 3 is a diagram depicting an example layout of the 
“Custom Circuit Board” shoWn in FIG. 1 for performing the 
parallel processing and combining of signals from tWo sets of 
eight photomultiplier tubes by tWo identical circuits. 
FIGS. 4A and 4B, in combination, represent a diagram 
depicting an example of an ampli?er-comparator of the 
example “Custom Circuit Boar ” shoWn in FIG. 3. 
FIG. 5 is a diagram depicting digital output pulses from 
tWo channels of the “Custom Circuit Board” of FIG. 1. 
FIG. 6 is a graph of cell counts vs. log propidum iodide 
?uorescence intensity (counts). 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention provides a method and system for 
detecting, distinguishing, and/or quantifying at least one 
detectably labeled cell or component thereof in a sample 
comprising one or more cells or components thereof, at least 
one cell or component thereof of Which is detectably labeled 
With at least tWo detectable labels, and, thus, has a level of 
sensitivity (i.e., a targeted cell or component thereof can be 
recogniZed in an overWhelming excess of very similar cells or 
components thereof) and a detection limit appropriate for 
non-ampli?ed samples. The detection and enumeration is 
substantially more selective and sensitive than detection by 
using conventional ?oW cytometry techniques. 
The present invention offers advantages over currently 
available detection means in that it enables the multiplexed 
detection and enumeration of cells or components thereof in 
the presence of antibody-conjugated detectable ?uorescent 
labels, While avoiding the conventional problem of “false 
positive” detection, attributable to ?uorescent antibody 
aggregation (i.e., aggregation of antibody-conjugated detect 
able ?uorescent labels together). The selectivity and sensitiv 
ity of the present invention is due in large part to the capacity 
for multiplexed and simultaneous detection of at least tWo 
detectable labels that are co-localiZed on a detectably labeled 
cell or component thereof. In this manner, “false positives” in 
detection and enumeration of detectably labeled cells or com 
ponents thereof of interest can be minimized or eliminated by 
ensuring that only those cells or components thereof, Which 
are simultaneously labeled With at least tWo detectable labels 
are counted, and that neither cells or component thereof, 
Which are not simultaneously labeled With at least tWo detect 
able labels, nor aggregates of antibody-conjugated detectable 
?uorescent labels (e. g., that form in the sample) are counted. 
The present invention also offers the advantage over currently 
available detection means of alloWing for multiplexed detec 
tion and enumeration of multiple different types of cells or 
components thereof, each With a unique combination of 
detectable labels. 
Moreover, the present invention provides a compact, e?i 
cient, and cost-effective system for use in the method. In the 
system, detectable emissions from at least tWo detectable 
labels on a detectably-labeled cell or component thereof are 
projected substantially directly or directly onto the array of 
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photomultiplier tubes, e.g., Without any intervening beam 
splitters and/or ?ber optic cables. 
The method comprises: 
(i) introducing a sample comprising one or more cells or 
components thereof, at least one cell or component thereof of 
Which is detectably labeled With at least tWo detectable labels, 
into one or more ?oW cells of a ?oW cytometer, 
(ii) irradiating the sample With one or more light sources 
that are absorbed by the at least tWo detectable labels, the 
absorption of Which is to be detected, and 
(iii) detecting simultaneously the absorption of light by the 
at least tWo detectable labels on the detectably labeled cell or 
component thereof With an array of photomultiplier tubes, 
Which are operably linked to tWo or more ?lters that selec 
tively transmit detectable emissions from the at least tWo 
detectable labels, Wherein the tWo or more ?lters and the array 
of photomultiplier tubes are operably linked to the one or 
more light sources by one or more optical bodies that project 
the detectable emissions from the at least tWo detectable 
labels to the tWo or more ?lters, 
Wherein the simultaneous detection of absorption of light 
by the at least tWo detectable labels indicates the presence of 
a detectably labeled cell or component thereof in the sample. 
The methods enable one or more detectably labeled cells or 
components thereof to be detected individually in a sample 
comprising one or more cells. For purposes of convenience, 
the term “cells” is intended to encompass cells, as Well as 
viruses, viroids, and prions. In this regard, cells are de?ned 
herein to be any suitable cell, such as a eukaryotic cell or a 
prokaryotic cell, e.g., bacterial cell, baculoviral system, fun 
gal cell (e.g., yeast), animal cell, such as an insect cell or a 
mammalian cell, or a plant cell. “Cellular components” is 
intended to encompass any and all of the foregoing even if not 
derived from a cell per se, such as any small molecules, 
carbohydrates, complex carbohydrates, nucleic acids (e.g., 
single-stranded, double-stranded, DNA, RNA, and hybrids 
thereof) and proteins (e.g., peptides, polypeptides and pro 
teins), Which can be glycosylated or glucosylated. In this 
regard, a sample comprising one or more cells or components 
thereof can comprise multiple small molecules, multiple mol 
ecules of nucleic acids, multiple molecules of proteins, or 
various combinations of the foregoing, Wherein multiple 
includes tWo or more. 
It Will be appreciated that the present invention can be used 
to detect, distinguish or quantify such “cells or components 
thereof” as pathogens (or antigens associated With patho 
gens). A “pathogen” is an etiolytic agent that can cause dis 
ease. The present invention can be used to detect pathogens, 
such as viruses, viroids, bacteria, fungi, prions, parasites and 
the like. In this regard, the present invention can be used to 
detect pathogens, such as HIV, hepatitis A, B and C viruses, 
tuberculosis, chlamydia, gonorrhea, brachematis, a protein 
marker for AlZheimer’s disease, Neisseria gonorrhoeae, 
Wbrio cholerae, syphilis (Treponema pallidum), Herpes 
viruses, human papilloma virus, tuberculosis (Mycobacte 
rium tuberculosis), and group A streptococcus. 
The present invention also can be used to detect, distin 
guish and/ or quantify pathogens in any suitable sample, e. g., 
food, beverages (e.g., soda, bottled Water, fruit juice, beer, 
Wine and liquor products), Water, pharmaceutical products, 
personal care products, dairy products and environmental 
samples. The present invention also can be used to detect 
pathogens in raW materials, equipment, products or processes 
used to manufacture or store food, beverages, Water, pharma 
ceutical products, personal care products, dairy products or 
environmental samples. In this regard, the present invention 
can be used to detect and/or quantitate, e.g., (l) livestock 
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diseases, such as Taxoplasma gondii, Brucella abortus, 
Stephanuras dentatus, Mycoplasma bovis, Bovine rhinotra 
cheitis, Maedi visna virus, swine fever virus, Leptospira 
interrogans, and coronavirus; (2) toxins and pathogens, such 
as Clostridium botulinum neurotoxin A, B, E, F, or G, Sta 
phylococcus aureus, enterotoxins A, B, C, D, E, a?atoxins 
B1, B2, B4 diol, M1, Q1, Ochratoxin, T-2 toxin, 3'-OH-T-2 
toxin, T-2 tetranyltetraacetate, HT-2 toxin, group A trichoth 
ecenes, roridin A, diacetoxyscirpenol, deoxynlvalonel, 
3-acetyl deoxynivalenol, deoxyverrucarol, Zearalenone, 
sterigmatocystin, rubratoxin B, PR toxin, Salmonella, List 
eria monocytogenes, Escherichia coli, I/ibrae epp., Yersinia 
enterocolitica, and Campylobacterjejuni, (3) pesticides and 
compounds, such as dioxins, dibenZofurans, PCB’s, triaZine, 
aldrin, alachlor, atraZine, Bacillus thuringensis toxin, BAY 
SIR 8514, S-bioallethin, chlorosulfuron, cyanZine, 2,4-D, 
DDT, dichlorfop-methyl, dieldrin, difubenZuron, endosulfon, 
iprodione, kepone, maleate hydraZide, metalaxyl, oxfenda 
Zole, parathlon, panoxon, paraquat, pentachlorophenol, 2,4, 
5-T, terbutryn, triadimefon, and Warfarin; and (4) anabolic 
agents, such as 17[3-estradiol, estrogen, testosterone, 
17.alpha.-methyltestosterone, progesterone, trenbolone, 
diethylstilbestrol, hexoestrol, and Zeronat. 
The present invention also can be used to detect, distin 
guish and/or quantify pathogens in clinical samples, clinical 
specimens, clinical environments, and equipment, ?xtures 
and/or products used to treat humans or animals. In this 
regard, the detection, identi?cation and/or quantitation of 
certain organisms is particularly useful Where these organ 
isms comprise a group of pathogens for Which a contamina 
tion limit applies by industry standard or by governmental 
regulation. One such group of organisms is the bacterial 
pathogens of the United States Pharmacopoeia (USP bacte 
ria). USP bacteria include E. coli, the Salmonella genus, 
Pseudomonas aeruginosa, and Staphylococcus aureus. Food, 
beverage and pharmaceutical products are routinely exam 
ined for the presence, absence or number of these USP bac 
teria. The method can be used to detect, distinguish and/or 
quantify one or more organisms of interest in a sample 
Wherein the organisms are members of the bacterial species of 
E. coli, Staphylococcus aureus, Pseudomonas aeniginosa, 
Pseudomonas cepatia, Pseudomonas?uorescens, or organ 
isms of a bacterial genus including the Salmonella genus, 
Bacillus genus or Pseudomonas genus. 
Suitable “cells or components thereof’ for use in the 
present invention also include such cells as bioterrorism 
related pathogens as, e.g., Anthrax spores (Bacillus anthra 
cis), Ebola virus, Staphylococcus aureus enterotoxin B, Yel 
loW fever virus, cloned protein toxins (e.g., snake toxins and 
scorpion toxins), Lassa fever virus, Ricin, and Yersiniapestis. 
The present invention also can be used to detect, distin 
guish, and/or quantify such “cells or components thereof’ as 
disease-associated cells or components thereof. In this 
regard, it Will also be appreciated that the present invention 
can also be used for diagnostic purposes, through detection of 
cell antigens that are associated With disease and/ or disorders. 
Accordingly, the term “cell” includes, for example, virally 
infected cells (e.g., HIV-infected cells and hepatitis-infected 
cells) and cancer cells (e. g., cells derived from such cancers as 
leukemia, as Well as lung, stomach, skin, brain, liver, prostate, 
testes, bone marroW, bone, breast, and intestinal cancer). In 
this regard, the detectable labels used in the context of the 
present invention can be speci?c for such cellular antigens as 
prostate-speci?c antigen (associated With prostate cancer), 
BRCA-1 and BRCA-2 antigens (associated With many 
adenocarcinomas, including breast cancer, lung cancer, and 
pancreatic cancer), CAl25 (associated With ovarian cancer), 
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aberrant myelin basic protein (associated With AlZheimer’s 
disease), gp120 (associated With HIV infection and AIDS), 
MUC-l (associated With breast cancer), EBNA-1 (associated 
With Epstein Barr Virus infection), CA19.9 (associated With 
colorectal, stomach, and pancreatic cancers), TAG-72 (asso 
ciated With ovarian, stromal, and pancreatic cancers), and p53 
(associated With various cancers). 
The terms “detect,” “distinguish” and “quantify” are used 
collectively herein to encompass any and all methods associ 
ated With identifying the presence and/or absence of one or 
more detectably labeled “cells or components thereof ’ in any 
suitable sample, as de?ned herein. In this regard, any desired 
diagnoses, treatments, puri?cation processes, and/ or produc 
tion processes that are reasonably based upon the methods of 
detecting, distinguishing, and/or quantifying one or more 
detectably labeled “cells or components thereof,” as de?ned 
herein, are contemplated. 
By “detectably labeled” is meant that the cell or component 
thereof is labeled With a means of detection. Any suitable 
means of detection can be used. Such means are knoWn in the 
art. Preferably, the means of detection is a ?uorescent label. 
The labeling of a cell or component thereof With a means of 
detection is Within the ordinary skill in the art. As an illustra 
tive example, a?inity-based ?uorescent labels can be 
employed, such as ?uorescent-labeled antibodies, ?uores 
cent-labeled DNA, ?uorescent-labeled RNA, cell-surface 
binding probes, or other types of ?uorescent compounds. As 
is also knoWn, such labels can be attached to the cell or 
component thereof by direct labeling or by indirect attach 
ment, such as by sandWich labeling. In the context of the 
present invention, “detectably labeled” Will also be used to 
encompass cells or components thereof that are naturally 
detectable, such that they do not need to be labeled With a 
detection means. For example, certain nucleic acids and pro 
teins can ?uoresce under certain conditions. Preferred ?uo 
rescent labels include those ?uorescent dyes that absorb and 
?uoresce at red Wavelengths, in order to minimiZe interfer 
ence from any potential native ?uorescence from cells or 
components thereof tested, due to the fact that feW naturally 
occurring molecules absorb in the red and near-infrared spec 
tral regions. 
It is suitable to utiliZe 2 or more (e.g., 3 or more, 4 or more, 
6 or more, 8 or more, or even 10 or more) different detectable 
labels in the context of the present invention. Moreover, it is 
suitable, for example, to use tWo or more different detectable 
labels, Which target different cellular components (e.g., one 
?uorescent label that binds speci?cally to a cell-surface anti 
gen and one ?uorescent label that binds speci?cally to DNA). 
For example, CyTM 5.5 (Amersham Biosciences, PiscataWay, 
N1.) and SYTOTM 61 (Invitrogen, Carlsbad, Calif.) can be 
used in the present invention. While CyTM 5.5, Which has a 
maximum ?uorescence intensity at 694 nm, can be attached 
to antibodies for immunorecognition-based cellular (e.g., 
bacterial) identi?cation, SYTOTM 61, Which has a maximum 
?uorescence intensity at 675 nm, is a cell-permeable, DNA 
stain. Moreover, the ?uorescent labels phycoerytherin and 
?uorescein isothiocyanate are suitable for use in the present 
invention. 
FIG. 1 illustrates an example system for detections of cells 
or components thereof, in accordance With an embodiment of 
the present invention. In particular, the example system is 
shoWn to comprise a ?oW cell 10 into Which a sample 12 
comprising one or more cells or components thereof are intro 
duced, a light source or laser 14 Which projects through a band 
pass ?lter 16 upon the contents of the ?oW cell 10. The 
example system also comprises a sheath ?oW component 20 
having a regulator 22, a sheath solution container 24, an air 
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cylinder 26, and a ?oW sensor 28. Moreover, the example 
system comprises a core ?oW component 30 having a syringe 
pump 32, a sample carrier solution container 34, and a sample 
injection component 36. The example system also comprises 
an optical body 40 having an objective lens 42, an edge ?lter 
44, and a notch ?lter 46, Which transmit detectable emissions 
from at least tWo detectable labels on the one or more cells or 
components thereof in the sample 12 in the ?oW cell 10 to an 
array of photomultiplier tubes 100, having a ?rst set 102 of at 
least eight PMT’s and a second set 106 of at least eight PMT’ s 
(With each set of PMT’ s 102 and 106 having different types of 
?lters thereon). The example system also comprises a custom 
circuit board 200, Which has outputs to a computer 300 With 
a computer board. 
The one or more ?oW cells 10 used in the context of the 
present invention can be any suitable ?oW cell (e.g., sheath 
?oW sample cell) for irradiation of a sample comprising one 
or more detectably labeled cells or components thereof. 
Moreover, it is contemplated in the present invention to have 
multiple parallel or non-parallel ?oW cells for the passing of 
identical, substantially identical, or different samples at iden 
tical (e.g., substantially identical) times for detection and/or 
enumeration of one or more detectably labeled cells or com 
ponents thereof. In this regard, the present invention can 
comprise tWo or more ?oW cells, e.g., 3 or more, 4 or more, 6 
or more, 8 or more, or even 10 or more ?oW cells. As knoW in 
the art, the ?oW cell used in the context of the present inven 
tion can be made out of any suitable material. Preferably, the 
?oW cell is a 250 um, square-bore quartz cell. Most prefer 
ably, the ?oW cell is a 250 um, square-bore quartz cell, Which 
employs hydrodynamic focusing through utiliZation of a 
pneumatically driven sheath of Water (i.e., sheath ?oW). 
Any suitable means can be used to introduce a sample into 
the one or more ?oW cells. For example, a syringe pump 32 
can be used for sample introduction. 
Any one or more light sources 14 (e. g., one or more lasers 
or laser diodes) can be used in the context of the present 
invention to irradiate the at least tWo detectable labels. Desir 
ably, the one or more light sources 14 comprise or consist 
essentially of one or more (e.g., tWo or more, three or more, 
?ve or more, or even a full spectrum of) Wavelengths of light 
that Will be absorbed by the at least tWo detectable labels, the 
absorption of Which is to be detected. Which Wavelength(s) of 
light Will be absorbed by the at least tWo detectable labels can 
be determined using a standard absorption spectrometer. 
Preferably, the light directed at the sample is red light, e.g., a 
red laser diode. It is suitable, for example, for the light source 
14 to be a 635-nm, 12.5 mW diode laser module, such as one 
packaged With an integrated drive circuit, for ?uorescence 
excitation. 
The one or more light sources 14 used in the context of the 
present invention can be positioned in any suitable orientation 
around the ?oW cell 10, such that the sample passing through 
the one or more ?oW cells 10 can be suitably irradiated. It is 
suitable, for example, for the one or more light sources 14 to 
be circumferentially and perpendicularly arranged relative to 
the one or more ?oW cells 10 in the same plane. Alternatively, 
it is suitable for the one or more light sources 14 to be 
arranged in different planes, non-perpendicularly, and/ or 
non-circumferentially. Moreover, it is suitable, for example, 
for the one or more light sources 14 to have a substantially 
identical (e.g., identical) focal region in the one or more ?oW 
cells 10, e.g., such that individual cells or components thereof 
in a sample 12 can be irradiated simultaneously by tWo or 
more, e.g., three or more, four or more, six or more, or even 
eight or more light sources 14. 
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By “detectable emissions” is meant any form of energy that 
is emitted from a detectable label folloWing irradiation or 
excitation of the detectable label With one or more light 
sources 14, Which can be detected. For example, “detectable 
emissions” is meant to encompass any single Wavelength or 
multiple Wavelengths of ?uorescent light that is/are emitted 
upon irradiation of a ?uorescent detectable label. 
“Optical bodies” 40 are de?ned herein to be any suitable 
optics for collecting detectable emissions from at least tWo 
detectable labels and passing, projecting, and/or channeling 
the detectable emissions to an array of photomultiplier tubes. 
In this regard, the one or more optical bodies 40 used in the 
context of the present invention can be any suitable optical 
bodies. Preferably, the one or more optical bodies 40 com 
prise a microscope objective lens 42 (e.g., a 20x microscope 
objective). It is also preferable for the one or more optical 
bodies 40 used in the context of the present invention to 
comprise an edge ?lter 44 (e.g., a 643 nm edge ?lter) and/or 
a holographic notch ?lter 46 (e.g., a 635 nm holographic 
notch ?lter) to block scattered laser light. In one embodiment, 
the one or more optical bodies 40 comprise ?ber optic cables 
(e.g., a 6 to l bundle of ?ber optic cables), Which collect and 
channel detectable emissions from at least tWo detectable 
labels. In another embodiment, the one or more optical bodies 
40 project the detectable emissions from at least tWo detect 
able labels on a cell or cellular component of interest in a 
sample 12 directly (i.e., Without use of mechanical means) or 
substantially directly or directly to tWo or more ?lters that 
selectively transmit the detectable emissions to an array of 
photomultiplier tubes (PMT’s) 100. Preferably, the one or 
more optical bodies 40 do not comprise beam splitters and/or 
optic cables (e.g., ?ber optic cables). This embodiment is 
preferred, for example, because it reduces the siZe and cost of 
the method and system and makes the system more effective 
and/or e?icient. 
The tWo or more ?lters used in the context of the present 
invention can be any suitable ?lters. In this regard, the process 
of choosing appropriate ?lters to correspond to the particular 
at least tWo detectable labels used in the present invention is 
Well Within the ordinary skill in the art. Preferably, the tWo or 
more ?lters used in the context of the present invention are 
?lters optimiZed to detect ?uorescent emission bands speci?c 
to the emission spectrum of the detectable emissions of the at 
least tWo detectable labels. Suitable bandpass ?lters include, 
for example, 650 nm, 20 nm bandWidth and 700 nm, 20 nm 
bandWidth bandpass ?lters. Preferably, the tWo or more ?lters 
are operably linked to both (i) the one or more optical bodies 
40 and (ii) an array ofPMT’ s 100, such that, e.g., one or more 
?lters (i.e., “?rst ?lters”) selectively transmit the detectable 
emissions (e.g., ?uorescent Wavelengths) from one or more 
irradiated detectable labels to one subset of PMT’s in the 
array 102, While one more different ?lters (i.e., “second ?l 
ters”) selectively transmit the detectable emissions (e.g., ?uo 
rescent Wavelengths) from one or more different irradiated 
detectable labels to a different subset of PMT’s in the array 
106. A “subset ofPMT’s” in an array, in this regard, can be a 
single PMT or, alternatively, can be a combination of tWo or 
more PMT’ s, e.g., three or more PMT’ s, four or more PMT’s, 
?ve or more PMT’s, six or more PMT’s, or even seven or 
more PMT’s (e.g., eight or more, ten or more, or even tWelve 
or more PMT’s). For example, a “?rst ?lter” can transmit 
detectable emissions from an irradiated detectable label to a 
combination of eight PMT’s 102, and a “second ?lter” can 
simultaneously transmit detectable emissions from a second 
irradiated detectable label to a different combination of eight 
PMT’s in the array 106. In this regard, the tWo or more ?lters 
function to select the color of light that falls on each half of the 
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PMT array. For example, half of the PMTs of an array can be 
covered With a ?lter that transmits ?uorescence from the 
antibody stain (CyTM 5.5) and the other half of the PMT’s of 
the array can be covered With a ?lter that transmits DNA stain 
(SYTOTM 61) ?uorescence. This embodiment is illustrated in 
FIG. 1, Wherein “Laser” 14 is a 635-nm, 12.5 mW diode laser 
module packaged With an integrated drive circuit, “FloW 
Cell” 10 is a sheath-?oW sample cell consisting of a 250 um, 
square-bore quartz cell, “Objective 20x” 42 is a 20x micro 
scope objective, “Edge Filter” 44 is a 643 nm edge ?lter, 
“Notch Filter” 46 is a 635 nm holographic notch ?lter, “PMT 
Array” 100 is a detector comprised of a linear array of sixteen 
multi-alkali photocathodes that have a sensitivity range from 
350 nm to 850 nm, “CyTM 5.5 Filter” represents band-pass 
?lters covering eight of the sixteen multi-alkali photocath 
odes of the PMT array 102, Which are selective for lighted 
emitted from CyTM 5.5 ?uorescent detectable labels, 
“SYTOTM 61 Filter” represents band-pass ?lters covering 
eight of the sixteen multi-alkali photocathodes of the PMT 
array 106, Which are selective for light emitted from SYTOTM 
61 ?uorescent detectable labels, “Filter 1 Signal” and “Filter 
2 Signal” represent parallel circuits for processing signals 
from the CyTM 5.5 Filter and the SYTOTM 61 Filter, “Custom 
Circuit Board” 200 represents the circuit board for processing 
PMT outputs, and “Output 1 TTL Pulse,” “Output 2 TTL 
Pulse,” and “AND Output,” represent channels for transmit 
tance of positive digital output pulses, respectively, from “Fil 
ter 1 Signal,” “Filter 2 Signal,” and from both concurrently. 
The PMT’s used in the context of the present invention can 
be any suitable PMT’s. It is suitable, for example, for PMT’s 
to be multi-alkali photocathodes that have a sensitivity range 
from about 350 nm to about 850 nm. The PMT’s are collec 
tively referred to herein as an “array” (e.g., a multi-anode 
array) of PMT’s. In this regard, the “array” of PMT’s can 
comprise any suitable number of PMT’s. It is suitable, for 
example, for the array to comprise tWo or more PMT’ s, three 
or more PMT’s, four or more PMT’s, six or more PMT’s, 
eight or more PMT’s, ten or more PMT’s, tWelve or more 
PMT’s. Most preferably, the array of PMT’s comprise sixteen 
or more, e.g., 24 or more PMT’s, 40 or more PMT’s, 80 or 
more PMT’s, or even 200 or more PMT’s. In this regard, the 
number of PMT’s that are operably linked With individual 
?lters is important, in that the strength of the detection of 
emissions by particular irradiated detectable labels can be 
increased by choosing the appropriate number of associated 
PMT’s for each operably linked ?lter (e.g., choosing to asso 
ciate eight PMT’s With each type of bandpass ?lter). In this 
manner, background noise can be reduced to a minimum. 
Choosing the number of PMT’s to be operably linked to 
particular ?lters for use in the context of the present invention 
is Well Within the ordinary skill in the art. 
Processing of the signals from the array of PMT’s (e.g., 
multi-anode array of multi-alkali photocathode PMT’s) can 
be performed by any suitable circuit (or custom circuit) 
board. An example of a suitable circuit board layout is pro 
vided in FIG. 3. In particular, FIG. 3 illustrates PMT’s 100 in 
the form ofarray 102, Which comprises eight PMT’s (“104-1” 
through “104-8”), and array 106, Which comprises eight 
PMT’s (“108-1” through “108-8”), Which, in this example, 
are operably-connected to circuit board 200 comprising tWo 
ampli?er-comparator circuits 212-1 and 212-2, anAND gate 
214, and an Inverter 216, Which is operably-connected to a 
computer device 300 (only partially depicted in FIG. 3). A 
more detailed illustration of suitable ampli?er-comparators 
210, for use as any or all of212-1, 212-2 . . .212-n is provided 
in FIGS. 4A and 4B. In particular, for example, the ampli?er 
comparator 210 can include an “offset & ?lter” circuit 214, a 
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“gain” circuit 215, a “mixer” circuit 216, a “threshold” circuit 
217, and a “pulse stretcher” circuit 218. 
In one embodiment, as illustrated in FIG. 3, the circuit 
board 200 can further include a signal monitor circuit 220, a 
high voltage module 230, a poWer circuit 240, and bypass 
capacitors 250. The poWer circuit 240 can provide the various 
+5V, —5V, and +24V DC outputs for the circuitry, as illus 
trated. A series of bypass capacitors 250 can be connected 
across the +5V and —5V terminals, as can be appreciated by 
one of skill in the art. As further indicated, the high voltage 
module 230 receives the +24V DC and adjusts that voltage as 
appropriate to provide the high voltage signal to the PMT’s 
100. The signal monitor circuit 220 provides signals to, and 
receives signals from, the ampli?er-comparator circuits 210. 
In particular, the signal monitor 220 monitors signals “gain 1” 
and “gain 2” to the ampli?er-comparator circuits 210, and 
receives the signals “process gain 1” and “process gain 2” 
from the ampli?er-comparator circuits 210. The signal moni 
tor 220 also outputs the “threshold” signals (“threshold 1” 
and “threshold 2”) to the ampli?er-comparator circuits 210, 
and receives the “comp 1” and “comp 2” signals from the 
ampli?er-comparator circuit 210. Furthermore, the signal 
monitor 220 also outputs a high voltage adjustment signal to 
the high voltage module 230. The signal monitor 220 can 
adjust the threshold levels (“threshold 1” and “threshold 2”) 
as necessary based on its monitoring of the signals “Gain 1,” 
“Gain 2,” “Process Gain 1,” “Process Gain 2,” “Comp 1,” and 
“Comp 2,” as are provided by the ampli?er-comparator cir 
cuits 210. The signal monitor 220 can be any type of proces 
sor or controller, as Would be understood by one of skill in the 
art. Furthermore, it is noted that, although the circuits, such as 
the signal monitor 220, high voltage module 230, poWer 
circuit 240, and bypass capacitors 250, are illustrated in this 
example as being on the circuit board 200, these components 
can be on separate circuit boards or part of other modules, as 
can be appreciated by one of skill in the art. 
It is suitable, for example, for the signals from tWo or more 
subsets of PMT’s in an array to be combined and processed in 
parallel by tWo or more identical or substantially identical 
circuits, e.g., for the signals from tWo subsets of eight PMT’s 
to be combined and processed in parallel by tWo identical 
circuits, as is illustrated in FIGS. 4A and 4B. 
Any suitable number of circuits can be utiliZed in the 
context of the present invention to amplify pulsed PMT out 
puts and to distinguish background noise from true detection 
events of the at least tWo detectable labels. In this regard, it is 
preferable that the circuits of the circuit board have the capac 
ity to generate digital output pulses When and only When the 
magnitude of an incoming signal the ?rst and/or second ?lter 
(e.g., ?rst and/or second bandpass ?lter) exceeds a selectable 
threshold. The selection of appropriate thresholds for the tWo 
or more (e.g., three or more, four or more, six or more, or even 
eight or more) circuits is Within the ordinary skill in the art, 
and is based on a balancing of both the desire to maximiZe 
detection of irradiated detectable labels and the desire to 
minimiZe background noise. The digital pulses from the tWo 
or more circuits or channels preferably are sent (i.e., relayed 
or transmitted) to an AND gate. An “AND gate” is de?ned 
herein as a circuit, Which generates an output signal only 
When input pulses corresponding to those PMT’s detecting 
each of the at least tWo detectable labels are presented con 
currently or substantially concurrently, as illustrated in FIG. 
5. In this manner, the e?iciency and effectiveness associated 
With detection and enumeration of detectably labeled cells or 
components thereof is increased or enhanced, due to the fact 
that the AND gate Will only “?re” output signals When there 
is simultaneous or substantially simultaneous detection of all 
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of the at least tWo detectable labels. This, in turn, Will only 
occur When a cell or component thereof that is detectably 
labeled With at least tWo detectable labels passes through the 
detection region of the one or more ?oW cells used in the 
context of the present invention. 
The output pulses of the AND gate can be processed or 
computed in any manner knoWn in the art. For example, the 
output pulses of the AND gate can be counted by a counter/ 
timer board (National Instruments NI 6602) to determine the 
number of cells or components thereof (e.g., bacteria) in the 
sample, as illustrated in FIG. 6. The present method, thus, can 
be used for such purposes as testing products (e.g., food or 
beverages) for contamination, testing human ?uid samples 
for diagnostic purposes. 
In addition to the above method, the present invention 
provides systems for use in the above method. One embodi 
ment of the system comprises: 
(i) tWo or more ?oW cells, into Which canbe placed samples 
comprising one or more cells or components thereof, at least 
one cell or component thereof of Which is detectably labeled 
With at least tWo detectable labels, 
(ii) one or more light sources that are absorbed by the at 
least tWo detectable labels, the absorption of Which is to be 
detected, and 
(iii) an array of photomultiplier tubes, Which are operably 
linked to tWo or more ?lters that selectively transmit detect 
able emissions from the at least tWo detectable labels, 
Wherein the tWo or more ?lters and the array of photomulti 
plier tubes are operably linked to the one or more light sources 
by one or more optical bodies, Which project the detectable 
emissions from the at least tWo detectable labels to the tWo or 
more ?lters. 
Another embodiment of the system comprises: 
(i) one or more ?oW cells, into Which can be placed a 
sample comprising one or more cells or components thereof, 
at least one cell or component thereof of Which is detectably 
labeled With at least tWo detectable labels, 
(ii) one or more light sources that are absorbed by the at 
least tWo detectable labels, the absorption of Which is to be 
detected, and 
(iii) an array of photomultiplier tubes, Which are operably 
linked to tWo or more ?lters that selectively transmit detect 
able emissions from the at least tWo detectable labels, 
Wherein the tWo or more ?lters and the array of photomulti 
plier tubes are operably linked to the one or more light sources 
by one or more optical bodies, Which project the detectable 
emissions from the at least tWo detectable labels to the tWo or 
more ?lters, Wherein the optical bodies do not comprise optic 
cables. 
Any suitable sample 12 containing any suitable one or 
more detectably labeled “cells or components thereof’ can be 
used in the present inventive system, as discussed above With 
respect to the method. In this regard, the system can be used 
to detect, distinguish and/or quantify multiple different, sub 
stantially identical, or identical samples at substantially iden 
tical or identical times, Wherein each sample 12 contains one 
or more different, substantially identical, or identical cells or 
components thereof. 
The one or more ?oWs cells 10 (e.g., tWo or more ?oW cells) 
used in the present system can be any suitable ?oW cell (e.g., 
sheath-?oW sample cell) for irradiation of the one or more 
samples 12 comprising one or more detectably labeled cells 
or components thereof, as discussed above With respect to the 
method. In this regard, it is contemplated in the present sys 
tem to have multiple substantially parallel or parallel or non 
parallel ?oW cells for the passing of the multiple different, 
substantially identical, or identical samples containing one or 
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more different, substantially identical, or identical thereof. 
Moreover, the present invention may comprise three or more 
?oW cells, e.g., 6 or more, 12 or more, or even 16 or more ?oW 
cells. As noted above, the ?oW cell 10 used in the context of 
the present invention can be made out of any suitable material 
and any suitable means can be used to introduce a sample into 
the one or more (e.g., tWo or more) ?oW cells of the present 
system. 
The one or more light sources 14 used in the present system 
can be any suitable light sources, as described above With 
respect to the present inventive method. Moreover, the one or 
more light sources 14 can be positioned in any suitable ori 
entation around the one or more (e.g., tWo or more) ?oW cells 
10, as described. 
The one or more optical bodies 40 used in the present 
system can be any suitable optics for collecting detectable 
emissions from at least tWo detectable labels and passing, 
projecting, and/or channeling the detectable emissions to an 
array of PMT’s 100, as discussed above. Preferably, the sys 
tem has a suitable number of optical bodies to operably link 
the ?oW cells 10 of the system to the array of PMT’s 100, such 
that the detection emissions from the at least tWo detectable 
labels is adequately directed to the array 100. In this regard, it 
is Well Within the ordinary skill of the art to determine hoW 
many optical bodies must be included in the system, e.g., one 
optical body for each ?oW cell, one optical body for each tWo 
?oW cells, or even one optical body for each sixteen ?oW cells. 
The tWo or more ?lters can be any suitable ?lters, as 
described above. Moreover, the tWo or more ?lters can selec 
tively transmit the detectable emissions from at least tWo 
detectable labels to any suitable number of “subsets” of 
PMT’s, Which can be made out of any suitable material, and 
Which are operably linked to any suitable ?lters, as described 
above With respect to the method. The system may further 
comprise any suitable number of circuits, preferably With an 
AND gate, as described above, and the output pulses of the 
AND gate can be processed or computed in any manner 
knoWn in the art. 
EXAMPLES 
The present invention is further demonstrated by Way of the 
folloWing examples, Which serve to illustrate the present 
invention but are not intended to limit its scope in any Way. 
SYTOTM 61 is a detectable ?uorescent label, Which is a 
cell-permeable, DNA stain, and Which has an absorption 
maximum at 628 nm and a ?uorescence maximum at 645 nm. 
CyTM 5.5 is a detectable ?uorescent label, Which can be 
attached or conjugated to antibodies for immunorecognition 
based bacterial identi?cation, and Which has a maximum 
?uorescence intensity at 694 nm and an absorption maximum 
at 675 nm. All bacteria used in the tests illustrated in 
Examples 1 and 2 Were heat-killed. 
Staining With CyTM 5.5-labeled anti-E. coli O157:H7 anti 
body. E. coli Was stained With CyTM 5.5 detectable labels in 
the folloWing manner: 50 pL of stock E. coli O157:H7 (~1>< 
109 cells/mL) Were diluted With 900 pL of phosphate-buff 
ered saline (PBS) containing 0.05% TWeen20 (Sigma, St. 
Louis, Mo.). 50 pL CyTM 5.5-labeled anti E. coli O157:H7 
antibody Were added, and the solution Was incubated at 37° C. 
for 1 hour With mild rotation (~85 rpm). Further dilution Was 
done With PBS containing 0.05% TWeen20. 
Staining With SYTOTM 61 nucleic acid stain. 50 pL of stock 
E. coli O157:H7 (~1><109 cells/mL) Were diluted With 920 pL 
of PBS containing 0.05% TWeen20 (Sigma). Stock SYTOTM 
61 dye solution Was diluted 50>< With deioniZed Water. Thirty 
pL of diluted dye Were added to E. coli O157:H7, and the 
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solution Was incubated at room temperature for 30 minutes. 
Further dilution Was done With PBS containing 0.05% 
TWeen20. 
Dual staining With CyTM 5 .5 anti-E. coli O157 antibody and 
SYTOTM 61 nucleic acid stain. 50 pL of stock E. coli 0157: 
H7 (~1><109 cells/mL) Were diluted With 870 pL of PBS 
containing 0.05% TWeen20. Fifty pL of CyTM 5.5-labeled anti 
E. coli O157:H7 antibody Were added, and the solution Was 
incubated at 370 C. for 1 hour With mild rotation (~85 rpm). 
Stock SYTOTM 61 dye solution Was diluted 50>< With deion 
iZed Water and ~30 uL diluted dye Were added to the incu 
bated solution. Then, the solution Was incubated at room 
temperature for 30 minutes. Further dilution Was done With 
PBS containing 0.05% TWeen20. 
The folloWing assay parameters Were utiliZed in Examples 
1 and 2: Sample loop: 500 uL; Sheath ?oW rate: 5-6 mL/min 
@ 3 psig air pressure; Syringe dispensation or core ?oW rate: 
0.498 mL/min; Syringe push volume for each test: 2 mL; 
Time required for each test: ~4 min Sheath/Core ?oW ratio 
~10-12; Calculated core diameter: (Core ?oW rate/Sheath 
?oW rate)l/2><(FloW channel diameter):>~70 um; Voltage 
applied to PMT: ~—900 V; Threshold voltage for SYTOTM 61 
channel: 0.375 V and CyTM 5.5 channel: 0.365 V. 
Example 1 
This example demonstrates the e?iciency and effective 
ness of the present invention in quantifying cells (e. g., bacte 
ria), due to a lessening of “false positive” detections. 
E. coli O157:H7 and Staphylococcus epidermidis Were 
stained With SYTOTM 61, (ii) CyTM 5 .5-labeled anti-E. coli 
O157:H7, or (iii) simultaneously With both detectable labels, 
and the number of counts in each of the three detection chan 
nels (i.e., the “SYTOTM 61 detection channel,” the “CyTM 5.5 
detection channel,” and the “AND gate channel”) Were mea 
sured. It Was expected that the Staphylococcus epidermidis 
sample Would only produce counts (i.e., “detection events”) 
in the SYTO channel, due to the knowledge in the art that 
Staphylococcus epidermidis can not be stained by the CyTM 
5.5-labeled antibody, but can be stained by SYTOTM 61. 
Moreover, it Was expected that E. coli O157:H7 Would pro 
duce counts or detection events in all three signal channels 
(i.e., the “SYTOTM 61 detection channel,” the “CyTM 5.5 
detection channel,” and the “AND gate channel”), due to the 
knowledge in the art that E. coli O157:H7 can be stained by 
both detectable labels. Control samples Were also run that did 
not contain any bacteria but Were otherWise treated in the 
same manner as the other samples. The results are given in 
Table 1. 
TABLE 1 
Expected AND 
SYTO TM61 Cy TM55 AND gate counts for 
channel channel gate 500 pL sample 
Sample counts counts counts loop 
Control stained With 403 88 79 0 
SYTO TM61 
Control stained With 45 891 31 0 
antibody-conjugated 
Cy TM55 
Control-Dual 427 924 89 0 
Stained 
E.c0liO157:H7 25,171 621 232 0 
stained With 
SYTO TM61 
E.c0li O157:H7 158 26,021 103 0 
stained With 
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TABLE 1-continued 
Expected AND 
SYTO TM61 Cy TM5.5 AND gate counts for 
channel channel gate 500 pL sample 
Sample counts counts counts loop 
antibody 
conjugated Cy TM55 
E. coli O157:H7- 26,732 27,679 26,028 500,000 
Dual Stained 
Staphylococcus 15,356 463 187 0 
epidermidis stained 
With SYTO TM61 
Staphylococcus 59 832 46 0 
epidermidis stained 
With antibody 
conjugated Cy TM55 
Staphylococcus 14,197 776 102 0 
epidermidis-Dual 
Stained 
Table 1 illustrates that dual staining (i.e., With CyTM 5 .5 and 
SYTOTM 61) and simultaneous detection via the “AND gate” 
reduce the number of false counts. In particular, as demon 
strated in Table 1, While the CyTM 5.5 control, dual-stained 
control, and the Staphylococcus epidermidis With CyTM 5.5 
samples do not bind With the CyTM 5.5 detectable label, these 
samples exhibited relatively high CyTM 5.5 channel counts 
(i.e., 89, 924, and 832, respectively), due in all likelihood to 
the detection of antibody aggregates. In contrast, the same 
CyTM 5.5 control, dual-stained control, and the Staphylococ 
cus epidermidis With CyTM 5.5 samples exhibited relatively 
loW “AND gate” counts (i.e., 31, 89, and 46, respectively), 
thus eliminating the detection of antibody aggregates. 
Moreover, as demonstrated in Table 1, there is minimal 
cross-reactivity of anti-E. coli O157 antibody With non-target 
bacteria. In particular, the Staphylococcus epidermidis Was 
single- and dual-stained to detect any cross-reactivity of anti 
E. coli O157 antibody. Counts in the case of CyTM 5.5 stained 
Staphylococcus epidermidis in the CyTM 5.5 channel are simi 
lar to the CyTM 5.5 staining control, Which Were due to CyTM 
5.5 anti-E. coli O157 antibody aggregates. Thus, no signi? 
cant AND gate counts Were observed in the case of stained 
Staphylococcus epidermidis, Which indicates minimal cross 
reactivity of anti-E. coli O157 antibody With non-target bac 
teria. 
In the case of SYTOTM 61-containing controls and 
SYTOTM 61-stained bacteria, higher AND gate counts Were 
observed than Were seen With the CyTM 5 .5 control and CyTM 
5.5-stained Staphylococcus epidermidis. We attribute this to 
the overlapping of SYTOTM 61 ?uorescence With the CyTM 
5 .5 detection Wavelength band. In contrast, CyTM 5.5 ?uores 
cence overlaps very little With the SYTOTM 61 detection 
band. 
This example, thus, demonstrates that simultaneous detec 
tion of at least tWo detectable labels on a cell or component 
thereof, Which is detectably labeled With at least tWo detect 
able labels, enhances the ef?ciency and effectiveness of cell 
detection and quanti?cation, due to a lessening of “false posi 
tive” detections. 
Example 2 
This example demonstrates the ef?ciency and effective 
ness With Which the present invention can be used to selec 
tively detect and count target cells (e. g., bacteria) in a sample 
containing a variety of cells. 
Target bacterial cells (i.e., E. coli O157:H7 dual-stained 
Withboth SYTOTM 61 and CyTM 5.5-labeled anti-E coli O157: 
US 7,473,529 B1 
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H7 antibody, as described above) and non-target bacterial 
cells (i.e., Staphylococcus epidermidis dual-stained With both 
SYTOTM 61 and CyTM 5.5-labeled anti-E coli O157:H7 anti 
body, as described above) Were mixed in the following ra?os: 
(1) in a ?rst sample, 50 pL ofE. coli O157:H7 Were mixed 
With 25 pL of Staphylococcus epidermidis, and (2) in a sec 
ond sample, 50 pL ofE. coliO157zH7 Were mixed With 50 pL 
of Staphylococcus epidermidis. Next, the number of counts in 
each of the three detection channels (i.e., the “SYTOTM 61 
detection channel,” the “CyTM 5 .5 detection channel,” and the 
“AND gate channel”) Were measured for the tWo samples. In 
this manner, the effect of an increasing concentration of non 
target bacterial cells on the detection and quanti?cation of 
dually-labeled target bacterial cells Was determined. 
The results of measurements of mixtures of E. coli 0157: 
H7 and Staphylococcus epidermidis are given in Table 2. 
TABLE 2 
SYTO TM61 
channel 
Ex- SYTO TM61 Cy TM55 AND minus 
pected channel channel gate AND gate 
Sample counts counts counts counts counts 
50 pL E. coli E. coli: 31,124 23,849 21,255 9,869 
O157:H7 + 500,000 
25 pL 
SlaphyZo- Staph.‘ 
coccas 150,000 
epidermidis 
50 pL E. coli E. coli: 40,927 28,321 23,611 17,316 
O157:H7 + 500,000 
50 11L 
SlaphyZo- Staph: 
coccas 300,000 
epidermidis 
The number of counts in the SYTOTM 61 channel represent 
the total number of bacteria (target and non-target), Whereas 
the CyTM 5.5 channel counts represent the number of target 
bacteria and aggregated antibodies. As illustrated in Table 2, 
the number of counts in the SYTOTM 61 channel increased as 
the total number of bacteria (target and non target bacteria) 
increased, Whereas the number of counts in the CyTM 5.5 
channel (target bacteria and aggregated antibody) remained 
roughly constant. The number of target bacteria alone is rep 
resented by the AND gate counts (i.e., Which ?res only When 
there are simultaneous signals presented in both SYTOTM 61 
and CyTM 5.5 channels). As illustrated in Table 2, the AND 
gate counts are loWer than the CyTM 5.5 channel counts. This 
is due an elimination of false count detection of antibody 
aggregates through utiliZation of simultaneous detection and 
the AND gate. 
The number of non-target bacteria number Was obtained by 
subtraction of AND gate counts (i.e., target bacteria) from 
SYTOTM 61 channel counts (i.e., target and non target bacte 
ria). This number approximately doubled When the number of 
Staphylococcus epidermidis Was doubled, While the AND 
gate counts shoWed only a small increase. 
This example demonstrates the e?iciency and effective 
ness of the present invention in selectively quantifying target 
bacteria in the presence of non-target bacteria and antibody 
aggregates. 
All sources (e. g., inventor’s certi?cates, patent applica 
tions, patents, printed publications, repository accessions or 
records, utility models, and the like) referred to or cited any 
Where in this document or in any draWing, Sequence Listing, 
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or Statement ?led concurrently hereWith are hereby incorpo 
rated into and made part of this speci?cation by such refer 
ence thereto. 
The foregoing is an integrated description of the invention 
as a Whole, not merely of any particular element or facet 
thereof. The description describes several preferred embodi 
ments” of this invention, including the best mode knoWn to 
the inventors for carrying it out. Of course, upon reading the 
foregoing description, variations of those preferred embodi 
ments Will become obvious to those of ordinary skill in the art. 
The inventors expect ordinarily skilled artisans to employ 
such variations as appropriate, and the inventors intend for the 
invention to be practiced otherWise than as speci?cally 
described herein. Accordingly, this invention includes all 
modi?cations and equivalents of the subject matter recited in 
the claims appended hereto as permitted by applicable laW. 
What is claimed is: 
1. A method for detecting a detectably labeled cell or 
component thereof in a sample, Which method comprises: 
(i) introducing a sample comprising one or more cells or 
components thereof, at least one cell or component 
thereof of Which is detectably labeled With at least tWo 
detectable labels, into one or more How cells of a How 
cytometer, 
(ii) irradiating the sample With one or more light sources 
that are absorbed by the at least tWo detectable labels, the 
absorption of Which is to be detected, and 
(iii) detecting simultaneously the absorption of light by the 
at least tWo detectable labels on the detectably labeled 
cell or component thereof With an array of photomulti 
plier tubes, Which are operably linked to tWo or more 
?lters that selectively transmit detectable emissions 
from the at least tWo detectable labels, Wherein the tWo 
or more ?lters and the array of photomultiplier tubes are 
operably linked to the one or more light sources by one 
or more optical bodies, Which do not comprise beam 
splitters or optic cables and Which project the detectable 
emissions from the at least tWo detectable labels to the 
tWo or more ?lters, 
Wherein the simultaneous detection of absorption of light 
by the at least tWo detectable labels indicates the pres 
ence of a detectably labeled cell or component thereof in 
the sample. 
2. The method of claim 1, Wherein the at least one cell or 
component thereof of the sample is detectably labeled With at 
least tWo detectable labels that bind to at least tWo different 
types of cell components. 
3. The method of claim 2, Wherein the at least tWo detect 
able labels comprise at least one detectable label that binds to 
a cell-surface antigen and at least one detectable label that 
binds to a nucleic acid. 
4. The method of claim 1, Wherein the array of photomul 
tiplier tubes comprises a ?rst set of at least eight photomulti 
plier tubes, Which are operably linked to one or more ?rst 
?lters that selectively transmit detectable emissions from one 
of the at least tWo detectable labels to the ?rst set of at least 
eight photomultiplier tubes, and a second set of at least eight 
photomultiplier tubes, Which are operably linked to one or 
more second ?lters that selectively transmit detectable emis 
sions from one of the at least tWo detectable labels to the 
second set of at least eight different photomultiplier tubes, 
Wherein the detectable label detected by the ?rst set of at least 
eight photomultiplier tubes is different from the detectable 
label detected by the second set of at least eight photomulti 
plier tubes. 
